Topic Hub
25 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 25 of 25 clinical reviews.
A clinical deep-dive into lisdexamfetamine (Vyvanse) pharmacokinetics, dosing, absorption changes, and safety considerations following Roux-en-Y gastric bypass, sleeve gastrectomy, and other bariatric procedures.
Read clinical reviewA clinician-level review of how Vyvanse (lisdexamfetamine) affects kidney function, covering renal excretion pharmacokinetics, blood-pressure-driven risk, dose adjustment in CKD, and what current evidence says about long-term renal safety.
Read clinical reviewA clinician-level review of lisdexamfetamine (Vyvanse) use in patients with autoimmune conditions, covering pharmacology, drug interactions, immune-axis effects, and practical prescribing considerations backed by primary literature.
Read clinical reviewA physician-reviewed guide to how Vyvanse (lisdexamfetamine) suppresses appetite and reduces cravings, covering mechanisms, clinical trial data, timing, management strategies, and when to seek medical guidance.
Read clinical reviewA physician-reviewed look at how lisdexamfetamine (Vyvanse) affects bone mineral density, fracture risk, and growth in children and adults, with primary literature citations and clinical guidance.
Read clinical reviewA physician-level review of lisdexamfetamine (Vyvanse) and cancer risk signals, covering pharmacology, preclinical data, post-marketing surveillance, and current FDA labeling guidance.
Read clinical reviewA physician-reviewed, evidence-based review of lisdexamfetamine (Vyvanse) and its long-term cardiovascular effects, including heart rate, blood pressure, arrhythmia risk, and clinical monitoring protocols.
Read clinical reviewA physician-reviewed deep dive into how lisdexamfetamine (Vyvanse) affects cognitive function in ADHD and binge eating disorder, covering mechanisms, clinical trial data, dosing, and safety.
Read clinical reviewA physician-reviewed, evidence-based comparison of branded Vyvanse (lisdexamfetamine) and compounded lisdexamfetamine alternatives, covering pharmacology, bioequivalence, regulatory status, cost, and clinical decision-making for ADHD and binge eating disorder.
Read clinical reviewA physician-level GRADE analysis of lisdexamfetamine (Vyvanse) evidence across ADHD and binge eating disorder, covering key trials, effect sizes, safety data, and guideline recommendations.
Read clinical reviewA clinical deep-dive into how lisdexamfetamine (Vyvanse) affects hair and skin, covering the mechanisms behind hair shedding, skin picking, hyperhidrosis, and pallor, with primary-literature citations and practical management guidance.
Read clinical reviewA clinician-reviewed guide to how lisdexamfetamine (Vyvanse) affects liver function, including metabolism pathways, enzyme elevations, drug interactions, and monitoring protocols backed by primary literature.
Read clinical reviewA clinician-level review of how lisdexamfetamine (Vyvanse) affects mood, anxiety, emotional dysregulation, and psychiatric comorbidities in ADHD and binge eating disorder, with primary-literature citations and dosing guidance.
Read clinical reviewA physician-reviewed deep dive into how lisdexamfetamine (Vyvanse) is metabolized, how it raises energy expenditure and thermogenesis, and what this means for patients managing ADHD or binge eating disorder.
Read clinical reviewA clinician-level review of lisdexamfetamine (Vyvanse) microdosing protocols, pharmacokinetics, FDA-approved dosing, and the current state of evidence for sub-therapeutic dosing strategies in ADHD and binge eating disorder.
Read clinical reviewBoard-reviewed guide on lisdexamfetamine (Vyvanse) and muscle preservation: why lean mass loss occurs, which interventions work, and how to build a practical protocol for patients on ADHD or BED therapy.
Read clinical reviewA clinician-level guide to diagnosing and resolving Vyvanse (lisdexamfetamine) plateau and non-response, covering pharmacokinetics, dose optimization, adherence gaps, comorbidities, and when to switch agents.
Read clinical reviewA physician-reviewed guide to the lisdexamfetamine (Vyvanse) pre-surgery hold window, including when to stop the drug, why it matters, and how to manage ADHD symptoms around a surgical procedure.
Read clinical reviewA clinician-reviewed guide to lisdexamfetamine (Vyvanse) rebound effects after stopping, covering mechanisms, timelines, symptom patterns, tapering protocols, and when to seek care.
Read clinical reviewStep-by-step clinical guidance on restarting lisdexamfetamine (Vyvanse) after acute illness, covering dose titration, cardiovascular monitoring, drug interactions, and return-to-therapy criteria backed by primary literature.
Read clinical reviewHow temperature, light cycles, schedule changes, and seasonal mood shifts affect Vyvanse (lisdexamfetamine) dosing, storage, and clinical management. Board-reviewed guidance with primary-literature citations.
Read clinical reviewA physician-reviewed analysis of how lisdexamfetamine (Vyvanse) affects sexual function, including mechanisms, prevalence data, dose relationships, and clinical management strategies.
Read clinical reviewLisdexamfetamine (Vyvanse) compresses REM sleep, delays sleep onset, and reduces total sleep time in a dose-dependent pattern. This MD-level review covers polysomnographic data, mechanism, clinical management, and dosing strategies to minimize sleep disruption.
Read clinical reviewEvidence-based protocols for traveling across time zones with Vyvanse (lisdexamfetamine). Covers dose-timing adjustments, international scheduling laws, storage requirements, and physician documentation.
Read clinical reviewA clinician-reviewed, week-by-week guide to the first 30 days on Vyvanse (lisdexamfetamine) for ADHD and binge eating disorder, including dose titration, side-effect timelines, and what the clinical evidence actually shows.
Read clinical review